Corticotropin-Releasing Factor and Corticosterone Modulate the Anxiogenic-Like Effects of mCPP
dc.contributor.advisor | Michael Forster | |
dc.contributor.committeeMember | Robert Luedtke | |
dc.contributor.committeeMember | Patricia Gwirtz | |
dc.creator | Jenkins, Jennifer A. | |
dc.date.accessioned | 2019-08-22T21:43:17Z | |
dc.date.available | 2019-08-22T21:43:17Z | |
dc.date.issued | 1998-06-01 | |
dc.date.submitted | 2013-08-27T13:28:54-07:00 | |
dc.description.abstract | Jenkins, Jennifer A., Corticotropin-Releasing Factor and Corticosterone Modulate the Anxiogenic-Like Effects of mCPP. Doctor of Philosophy (Pharmacology), June 1998, 119 pp., 2 tables, 29 figures, bibliography, 100 titles. The administration of PTZ or mCPP produces anxiety-like behavior as measured by an increase in the percentage of entries into the open arms and the time spent on the open arms of the elevated plus maze (Prunell et al., 1994). Reportedly, PTZ and mCPP substitute for each other in the drug discrimination paradigm (Wallis and Laz, 1998). It is therefore suggested that commonality exists among anxiogenic drugs as perceived by trained animals. Andrews and Stephen (1990) suggested that this overall parallelism is an indication that anxiogenic agents may possess similar properties. Therefore, the question posed is as follows: Is there a common denominator anxiety? The global hypothesis is that the core component of anxiety produced by anxiogenic agents or processes involves stimulation of the HPA axis to release CRF, ACTH and/or CORT. Long Evans rats were trained to discriminate either mCPP (1.4 mg/kg) or PTZ (16mg/kg) from saline in a two-lever choice procedure (FR10) which is food reinforced. Animals were pretreated with CRF, α-helical CRF (a CRF antagonist), two steroid synthesis inhibitors (ketoconazole, KETZ and aminoglutethimide, AMG), CORT or underwent an adrenalectomy prior to behavioral testing in order to test the hypothesis that the release of CRF and/or CORT are components of the discriminate stimulus of the mCPP and/or PTZ. Pretreatment with CRF, KETZ, AMG and an adrenalectomy facilitated mCPP level selection. However in the absence of mCPP neither drug nor adrenalectomy produced drug lever selection. In addition CORT did not alter the mCPP dose response curve. However, CORT replacement therapy returned the does response curve to baseline in adrenalectomized animals. Alpha-helical CRF did not block mCPP discrimination. Unlike mCPP-trained animals, KETZ and AMG decreased PTZ-lever selection in PTZ-trained animals. In addition, CORT enhanced and partially substituted for the discriminative stimulus of PTZ. However, adrenalectomy completely abolished drug lever selection in PTZ animals. To compare the discriminative stimulus effects of mCPP and PTZ, PTZ-trained animals were injected with cumulative doses of mCPP. mCPP-trained animals were injected with cumulative doses of PTZ. mCPP and PTZ minimally substituted for each other. The results suggested that neither CRF nor CORT are components of the discriminative stimulus of mCCP and that the role of the HPA axis in mCPP discrimination maybe be a modulator of the stress response. However, CORT is a component of the discriminative stimulus of PTZ such that CORT is necessary for drug lever selection in PTZ trained animals. | |
dc.format.mimetype | application/pdf | |
dc.identifier.uri | https://hdl.handle.net/20.500.12503/29535 | |
dc.language.iso | en | |
dc.provenance.legacyDownloads | 0 | |
dc.subject | Animal Sciences | |
dc.subject | Behavioral Neurobiology | |
dc.subject | Behavior and Behavior Mechanisms | |
dc.subject | Cell and Developmental Biology | |
dc.subject | Chemical and Pharmacologic Phenomena | |
dc.subject | Chemicals and Drugs | |
dc.subject | Comparative and Laboratory Animal Medicine | |
dc.subject | Experimental Analysis of Behavior | |
dc.subject | Laboratory and Basic Science Research | |
dc.subject | Life Sciences | |
dc.subject | Medical Pharmacology | |
dc.subject | Medicinal Chemistry and Pharmaceutics | |
dc.subject | Medicine and Health Sciences | |
dc.subject | Molecular and Cellular Neuroscience | |
dc.subject | Neuroscience and Neurobiology | |
dc.subject | Other Chemicals and Drugs | |
dc.subject | Other Neuroscience and Neurobiology | |
dc.subject | Pharmacology | |
dc.subject | Psychiatry and Psychology | |
dc.subject | Psychological Phenomena and Processes | |
dc.subject | Psychology | |
dc.subject | Social and Behavioral Sciences | |
dc.subject | Veterinary Toxicology and Pharmacology | |
dc.subject | Corticotropin-releasing factor | |
dc.subject | corticosterone | |
dc.subject | anxiogenic-like effects | |
dc.subject | mCPP | |
dc.subject | anxiety-like behavior | |
dc.subject | Long Evans rats | |
dc.subject | drug lever selection | |
dc.subject | adrenalectomy | |
dc.subject | PTZ | |
dc.subject | CORT | |
dc.title | Corticotropin-Releasing Factor and Corticosterone Modulate the Anxiogenic-Like Effects of mCPP | |
dc.type | Dissertation | |
dc.type.material | text | |
thesis.degree.department | Graduate School of Biomedical Sciences | |
thesis.degree.discipline | Pharmacology and Neuroscience | |
thesis.degree.grantor | University of North Texas Health Science Center at Fort Worth | |
thesis.degree.name | Doctor of Philosophy |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Jenkins_Corticotropin_ReleasingFactorAnd.pdf
- Size:
- 61.3 MB
- Format:
- Adobe Portable Document Format